drugset / Trial / NCT01521403

Is it Effective to Treat Patients With Blastocystis Hominis Infection?

NCT01521403 ↗

Phase 4 Unknown 200 enrolled University of Lausanne Hospitals
RandomizedCrossoverQuadruple-blindTreatment

Summary

The objective of this study is to determine whether in the setting of primary health care it is effective to treat with metronidazole returning travellers with gastrointestinal symptoms and B. hominis in the stool or not.

Timeline

Start
2012-11
Primary completion
2018-12-31
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 500 mg —